Good news for some hard-to-treat hepatitis C patients
Wednesday, June 17, 2009 - 00:00
in Health & Medicine
In a multi-centre trial led by a Saint Louis University researcher, investigators found that a new combination therapy of daily consensus interferon and ribavirin helps some hepatitis C patients who have not responded to previous treatment. The findings, published in the June issue of Hepatology, offer a new option for hepatitis C patients, and may be effective even for those patients with factors that make their condition difficult to treat...